Skip to content

Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C

ANRS 12320 IMMHoTHep : Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02826447
Acronym
IMMHoTHep
Enrollment
550
Registered
2016-07-11
Start date
2017-02-21
Completion date
2018-04-30
Last updated
2017-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exposure to Hepatitis C Virus

Brief summary

This project is a prospective observational cohort study to quantify the risk of acquiring Hepatitis C virus (HCV) infection for patients and healthcare workers in Ain Shams University Teaching Hospital, Cairo, Egypt through: 1) identifying typical patient trajectories within the hospital; and 2) assessing the ward-specific risk based on the type and number of procedures performed and the prevalence of HCV viremia in patients within each ward.

Detailed description

Hepatitis C virus (HCV) is a blood-borne virus and its major route of transmission include blood transfusion, medical injection and procedure, and injecting drug use. In Egypt, the origin of the HCV epidemic has been attributed to a mass treatment of schistosomiasis between 1960 and 1984, when intravenous injections with antimony salts were given to 3-5 million people older than 6 years of age. Insufficient sterilization of needles and syringes was considered to be responsible for HCV transmission at that time. In order to control the spread of HCV in Egypt, the Egyptian Ministry of Health and Population established the National Committee for the Control of Viral Hepatitis. By 2008, this committee developed a National Control Strategy for Viral Hepatitis which has recommended prevention and education campaigns targeting general population and also healthcare workers (HCW). In their occupational environment, HCWs are frequently exposed to multiple blood-borne pathogens, including HCV. Several risk factors for HCV acquisition among patients and HCWs within a hospital ward have been identified, including a high prevalence of HCV infection in the ward, understaffing, workplace characteristic, and human factors such as inexperience or unfamiliar with equipment. However, to the investigators' knowledge, the overall risk of HCV acquisition associated with hospital stay has never been evaluated in Egypt. Also, control measures to reduce the risk of HCV transmission in hospital settings, based on a global assessment of healthcare provider logistics and performance, have never been proposed in Egypt. In this project, the investigators assume that HCV will be transmitted to both hospital staff and patients. Given the slow dynamics of the HCV epidemic, the investigators further hypothesize that, in the short term, the prevalence of HCV viremia among patients will be constant. Therefore, the investigators are led to conclude that HCV transmission risk may be inferred from a detailed description of individual trajectories of patients or staff within the hospital.

Interventions

None listed

Sponsors

Conservatoire national des Arts et Métiers
CollaboratorOTHER
Ain Shams University
CollaboratorOTHER
Institut Pasteur
CollaboratorINDUSTRY
ANRS, Emerging Infectious Diseases
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for patients: * Aged 21 years or older * Staying in the hospital more than 24 hours * Provided a written informed consent to participate Inclusion Criteria for healthcare workers: * Aged 21 or older * Provided a written informed consent to participate

Design outcomes

Primary

MeasureTime frameDescription
Per-day risk of HCV acquisition for a hospitalized patient1 dayPer-day risk of HCV acquisition for a hospitalized patient
Per-week risk of HCV acquisition for a healthcare worker through occupational blood exposure1 weekPer-week risk of HCV acquisition for a healthcare worker through occupational blood exposure

Secondary

MeasureTime frameDescription
Estimation of the number of HCV acquisitions among patients and HCWs prevented over a 1-year period following the implementation of various control strategies, using a mathematical modeling approach1 yearEstimation of the number of HCV acquisitions among patients and HCWs prevented over a 1-year period following the implementation of various control strategies,

Countries

Egypt

Contacts

Primary ContactLaura Temime, Professor
laura.temime@cnam.fr+33 1 53 01 80 11
Backup ContactWagida Anwar, Professor
wagidaanwar@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026